Codexis (CDXS) FCF Margin (QoQ) (2010 - 2026)
Codexis (CDXS) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,240.00 |
| Mar 31, 2026 | -13,089.00 |
| Dec 31, 2025 | 13,215.00 |
| Sep 30, 2025 | 1,788.00 |
| Jun 30, 2025 | 9,022.00 |
| Mar 31, 2025 | -10,392.00 |
| Dec 31, 2024 | -440.00 |
| Sep 30, 2024 | 6,621.00 |
| Jun 30, 2024 | -10,521.00 |
| Mar 31, 2024 | 25,368.00 |
| Dec 31, 2023 | -17,289.00 |
| Sep 30, 2023 | 22,033.00 |
| Jun 30, 2023 | -26,284.00 |
| Mar 31, 2023 | -15,294.00 |
| Dec 31, 2022 | 897.00 |
| Sep 30, 2022 | 6,418.00 |
| Jun 30, 2022 | 3,532.00 |
| Mar 31, 2022 | -2,638.00 |
| Dec 31, 2021 | 263.00 |
| Sep 30, 2021 | 934.00 |